@article{MumcuogluSiverinoTabiszetal.2017, author = {Mumcuoglu, Didem and Siverino, Claudia and Tabisz, Barbara and Kluijtmans, Bas and Nickel, Joachim}, title = {How to use BMP-2 for clinical applications? A review on pros and cons of existing delivery strategies}, series = {Journal of Translational Science}, volume = {3}, journal = {Journal of Translational Science}, number = {5}, doi = {10.15761/JTS.1000195}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-158678}, year = {2017}, abstract = {No abstract available.}, language = {en} } @article{SulimanMustafaKruegeretal.2016, author = {Suliman, Salwa and Mustafa, Kamal and Krueger, Anke and Steinm{\"u}ller-Nethl, Doris and Finne-Wistrand, Anna and Osdal, Tereza and Hamza, Amani O. and Sun, Yang and Parajuli, Himalaya and Waag, Thilo and Nickel, Joachim and Johannessen, Anne Christine and McCormack, Emmet and Costea, Daniela Elena}, title = {Nanodiamond modified copolymer scaffolds affects tumour progression of early neoplastic oral keratinocytes}, series = {Biomaterials}, volume = {95}, journal = {Biomaterials}, doi = {10.1016/j.biomaterials.2016.04.002}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-188287}, pages = {11-21}, year = {2016}, abstract = {This study aimed to evaluate the tumorigenic potential of functionalising poly(LLA-co-CL) scaffolds. The copolymer scaffolds were functionalised with nanodiamonds (nDP) or with nDP and physisorbed BMP-2 (nDP-PHY) to enhance osteoinductivity. Culturing early neoplastic dysplastic keratinocytes (DOK\(^{Luc}\)) on nDP modified scaffolds reduced significantly their subsequent sphere formation ability and decreased significantly the cells' proliferation in the supra-basal layers of in vitro 3D oral neoplastic mucosa (3D-OT) when compared to DOK\(^{Luc}\) previously cultured on nDP-PHY scaffolds. Using an in vivo non-invasive environmentally-induced oral carcinogenesis model, nDP scaffolds were observed to reduce bioluminescence intensity of tumours formed by DOK\(^{Luc}\) + carcinoma associated fibroblasts (CAF). nDP modification was also found to promote differentiation of DOK\(^{Luc}\) both in vitro in 3D-OT and in vivo in xenografts formed by DOKLuc alone. The nDP-PHY scaffold had the highest number of invasive tumours formed by DOK\(^{Luc}\) + CAF outside the scaffold area compared to the nDP and control scaffolds. In conclusion, in vitro and in vivo results presented here demonstrate that nDP modified copolymer scaffolds are able to decrease the tumorigenic potential of DOK\(^{Luc}\), while confirming concerns for the therapeutic use of BMP-2 for reconstruction of bone defects in oral cancer patients due to its tumour promoting capabilities.}, language = {en} } @phdthesis{Tabisz2017, author = {Tabisz, Barbara}, title = {Site Directed Immobilization of BMP-2: Two Approaches for the Production of Osteoinductive Scaffolds}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-153766}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2017}, abstract = {Bone fractures typically heal without surgical intervention. However, pathological situations exist which impede the healing process resulting in so-called non-union fractures. Such fractures are nowadays treated with scaffold material being introduced into the defect area. These scaffolds can be doped with osteogenic factors, such as bone morphogenetic protein (BMP)2. BMP2 belongs to the most osteogenic growth factors known to date. Its medical use, efficiency and safety have been approved by FDA for certain applications. Currently, BMP2 is distributed with a stabilizing scaffold, which is simply soaked with the growth factor. Due to fast release kinetics supraphysiological high doses of BMP2 are required which are causally associated with severe side effects observed in certain applications being most harmful in the area of the cervical spine. These side-effects include inflammation, swelling and breathing problems, leading to disastrous consequences or secondary surgical interventions. Since it could be shown that a retardation of BMP2 release from the scaffold resulted in superior bone forming properties in vivo, it seems obvious to further reduce this release to a minimum. This can be achieved by covalent coupling which in the past was already elaborated using mainly classical EDC/NHS chemistry. Using this technique coupling of the protein occurs non-site-directedly leading mainly to an unpredictable product outcome with variable osteogenic activities. In order to improve the reproducibility of scaffold functionalization by BMP2 we created variants one of which contains a unique unnatural amino acid substitution within the mature polypeptide sequence (BMP2-K3Plk) and another, BMP2-A2C, in which an N-terminal alanine has been substituted by cysteine. These modifications enable site-specific and covalent immobilization of BMP2 e.g. onto polymeric beads. Both proteins were expressed in E. coli, renatured and purified by cation-exchange chromatography. Both variants were extensively analyzed in terms of purity and biological activity which was tested by in vitro interaction analyses as well as in cell based assays. Both proteins could be successfully coupled to polymeric beads. The different BMP2 functionalized beads were shown to interact with the ectodomain of the type I receptor BMPR-IA in vitro indicating that the biological activity of both BMP2 variants retained upon coupling. Both functionalized beads induced osteogenic differentiation C2C12 cells but only of those cells which have been in close contact to the particular beads. This strongly indicates that the BMP2 variant are indeed covalently coupled and not just adsorbed. We claim that we have developed a system for a site-specific and covalent immobilization of BMP-2 onto solid scaffolds, potentially eliminating the necessity of high-dose scaffold loading. Since immobilized proteins are protected from removal by extracellular fluids, their activities now rely mainly on the half-life of the used scaffold and the rate of proteolytic degradation. Assuming that due to prolonged times much lower loading capacities might be required we propose that the immobilization strategy employed in this work may be further refined and optimized to replace the currently used BMP2-containing medical products.}, subject = {Protein chemistry}, language = {en} } @phdthesis{Huang2008, author = {Huang, Yi}, title = {Structural and Functional Analysis of Chordin-like 2/BMP-2 Interaction}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-29120}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2008}, abstract = {We have established the novel interaction between mCHL2, Tsg and BMP-2 for the first time. Tsg binds to VWC1 and VWC3 of mCHL2 in a cooperative waz and plazs a role in strengthening the binding affinity. Furthermore, Tsg/mCHL2/BMP-2 termary complex and Tsg/mCHL2 binary complex have been isolated by gel-filtration chromatography. Therefore mCHL2 can form a ternary complex with Tsg and BMP-2 and this complex makes mCHL2 a better BMP-2 antagnonist.}, language = {en} }